BOT 8.33% 39.0¢ botanix pharmaceuticals ltd

I have been looking at the Pharmi stocks as the minerals market...

  1. 2,776 Posts.
    lightbulb Created with Sketch. 38
    I have been looking at the Pharmi stocks as the minerals market is getting risky at the moment.

    With BOT they are expecting FDA approval by mid 2024 or June hence commercialising Sofpironium Bromide in the US on its own. The SP should go up a fair bit maybe double on that alone.

    Another one that has me on buy is SIG. They are looking to merge Priceline and their distribution network with Chemist Warehouse. It is seeking ACCC approval for the merger due 13th June. That will double down as well if it gets the tick.

    Hope that helps.

    PP

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
0.030(8.33%)
Mkt cap ! $622.1M
Open High Low Value Volume
36.5¢ 40.0¢ 36.5¢ $8.050M 20.84M

Buyers (Bids)

No. Vol. Price($)
14 874689 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 213746 11
View Market Depth
Last trade - 13.40pm 24/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.